CD8A and liver cancer: They revealed that liver cancer cells inhibit T cell function by hijacking glucose metabolism (such as lactic acid accumulation), and that interferon alpha (IFNα) combined with PD-1 inhibitors can reverse this phenomenon, significantly improving the mitochondrial activity and anti-tumor efficacy of CD8+ T cells (38).